C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities

Immunology

Volumn 95, Issue 4, 1998, Pages 648-654

  Chen, C H ^a   Lam, C F ^b   Boackle, R J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; MONOCLONAL ANTIBODY;

ANTIBODY AFFINITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING AFFINITY; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BLOTTING, WESTERN; COMPLEMENT ACTIVATION; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1Q; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICE;

EID: 0031742941     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00635.x     Document Type: Article

References (37)

1. ARLAUD G.J., COLOMB M.G. & GAGNON J. (1987) A functional model of the human C1 complex. Immunol Today 8, 106.
2. ARLAUD G.J., THIELENS N.M. & ILLY C. (1993) Assembly of the C1 complex. Behring Inst Mitt 93, 189.
3. BORSOS T. (1989) Immune complexes mediated activation of the classical pathway. Behring Inst Mitt 84, 93.
4. ZICCARDI R.J. (1984) The role of immune complexes in the activation of the first component of human complement. J Immunol 132, 283.
5. SCHUMAKER V.N., HANSON D.C., KILCHHERR E. & PHILIPS M.L. (1986) A molecular mechanism for the activation of the first component of complement by immune complexes. Mol Immunol 23, 557.
6. ARLAUD G.J., GAGNON J., VILLIERS C.L. & COLOMB M.G. (1986) Molecular characterization of the catalytic domains of human complement serine protease Clr. Biochemistry 25, 5177.
7. COLOMB M.G., ARLAUD G.J., AUDE C. & JOURNET A. (1987) The role of proteolytic enzymes in the complement system. Adv Biosci 65, 11.
8. COOPER N.Z. (1985) The classical complement pathway: activation and regulation of the first component. Adv Immunol 20, 53.
9. PORTER R.R. & REID K.B.M. (1979) Activation of the complement system by antibody and antigen complexes: the classical pathway. Adv Protein Chem 33, 1.
10. SCHUMAKER V.N., ZAVODSZKY P. & POON R.H. (1987) Activation of the first component of complement. Annu Rev Immunol 5, 21.
11. TOSI M., JOURNET A., PUPONCHEL C., COUTURE-TOSI E. & MEO T. (1989) Human complement C1r and C1s proteins and genes: Studies with molecular probes. Behring Inst Mitt 84, 65.
12. AULAK K.S., DONALDSON V.H., COUTINHO M. & DAVIS A.E. (1993) C1 inhibitor: structure/function and biologic role. Behring Inst Mitt 93, 204.
13. CHESNE S., VILLIERS C.L., ARLAUD G.J., LACROIX M.G. & COLOMB M.G. (1982) Fluid phase interaction of C1 INH (C1 INHIBITOR) and the first component of complement, C1. Biochem J 201, 61.
14. HORTIN G.L. & TRIMPE B.L. (1991) C1 Inhibitor: different mechanisms of reaction with complement component C1 and C1s Immunol Invest 20, 75.
15. LENNICK M., BREW S.A. & INGHAM K.C. (1986) Kinetics of interaction of C1 INH with complement C1s. Biochemistry 25, 3890.
16. PASTON A.A., GETTINS J., BEECHEM J. & SCHAPIRA M. (1991) Mechanism of serpin action: evidence that C1 INH functions as a suicide substrate. Biochemistry 30, 8876.
17. TSENG Y., POON P.H., ZAVODSZKY P. & SCHUMAKER V.N. (1991) Spontaneous activation of serum C1 in vitro role of C1 Inhibitor. J Immunol 147, 1884.
18. ZICCARDI R.J. & COOPER N.R. (1979) Active disassembly of the first complement component, C1, by C1 inactivalor. J Immunol 123, 788.
19. ZICCARDI R.J. (1982) A new role for C1 INH in homeostasis: control of activation of the first component of human complement. J Immunol 128, 2505.
20. ZICCARDI R.J. (1985) Demonstration of the interaction of native C1 with monomeric immunoglobulins and C1 Inhibitor. J Immunol 134, 2559.
21. SCHUMAKER V.N., POON P.H., SEEGAN G.W. & SMITH C.A. (1981) Semi-flexible joint in the C1q subunit of the first component of human complement. J Mol Biol 148, 191.
22. OKADA M. & UTSUMI S. (1989) Role for the third constant domain of the IgG H chain in activation of complement in the presence of C1 INH. J Immunol 142, 195.
23. LAURELL A.B., MARTENSSON U. & SJOHOLM A.G. (1987) C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r and zymogen C1s. J Immunol 139, 4145.
24. LAURELL A.B. & SJOHOLM A.G. (1993) C1 subcomponent complexes: basic and clinic aspects. Behring Inst Mitt 93, 292.
25. ZICCARDI R.J. (1986) Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition. J Immunol 136, 3378.
26. ANTON L.C., RUIZ S., BARRIO G., SANCHEZ A. & VIVANCO F. (1994) C3 binds with similar efficiency to Fab and Fe regions of IgG immune aggregates. Eur J Immunol 24, 599.
27. MOLLNES T.E., HOGASEN K., HOAAS B.F., MICHAELSEN T.E., GARRED P. & HARBOE M. (1995) Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the Ig isotype and its C1 binding properties. Scand J Immunol 41, 449.
28. KILCHHERR E., SCHUMAKER V.N., PHILLIPS M.L. & CURTISS L.K. (1986) Activation of the first component of human complement, Cl, by monoclonal antibodies directed against different domains of subcomponent C1q. J Immunol 137, 255.
29. HOEKZEMA R., MARTENS M., BROUWER M.C. & HACK C.E. (1988) The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the 'arms' of C1q. Mol Immunol 25, 485.
30. JIANG H., SIEGEL J.N. & GEWURZ H. (1991) Binding and complement activation by C-reactive protein via collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J Immunol 146, 2324.
31. CHESEBRO B. & WEHRLY K. (1998) Development of a sensitive quantitative focal assay for human immunodeficiency virus effectivity. J Virol 62, 3779.
32. SCATCHARD G. (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51, 660.
33. STEVENS F.J. (1987) Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. Mol Immunol 24, 1055.
34. BOACKLE R.J., CONNER M.H. & VESELY J. (1993) High molecular weight non-immunoglobulin agglutinins (NIA) bind C1q globular heads and have the potential to activate the first complement component. Mol Immunol 30, 309.
35. OLLERT M.W., KADLEC J.V., DAVID K., PETRELLA E.C., BREDEHORST R. & VOGEL C. (1994) Antibody-mediated complement activation on nucleated cells: a quantitative analysis of the individual reaction steps. J Immunol 153, 2213.
36. PERKINS S.J. (1993) Three-dimensional structure and molecular modelling of C1 Inhibitor. Behring Inst Mitt 93, 63.
37. 2 complex from immobilized human IgG subclasses. Clin Immunol Immunopathol 87, 68.